drugset / Trial / NCT02212275

Cortical Metrics in Intervention Trials With Autism Spectrum Disorders

NCT02212275

Non-randomizedSingle-groupOpen-label

Summary

The investigators overarching aim is to obtain preliminary data to support a larger grant to validate a novel objective, physiologically-based outcome measure for clinical trials in autism spectrum disorders (ASDs) called the cortical metric. Absence of such an outcome measure has greatly hindered the development of treatments for core symptoms of ASD.

Timeline

Start
2015-08
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown